Show simple item record

dc.contributor.authorAssemblée mondiale de la Santé, 50
dc.date.accessioned2015-12-10T10:21:47Z
dc.date.available2015-12-10T10:21:47Z
dc.date.issued1997
dc.identifier.govdocWHA50.3
dc.identifier.urihttp://www.who.int/iris/handle/10665/201576
dc.descriptionPoint 19 de l'ordre du jouren_US
dc.language.isofren_US
dc.publisherOrganisation mondiale de la Santéen_US
dc.subjectResolutions and decisionsen_US
dc.subjectPharmaceutical productsen_US
dc.subject.meshPharmaceutical Preparationsen_US
dc.subject.meshQuality Controlen_US
dc.subject.meshCommerceen_US
dc.subject.meshCertificationen_US
dc.subject.meshGuideline Adherenceen_US
dc.titleLignes directrices concernant l'application du système OMS de certification de la qualité des produits pharmaceutiques entrant dans le commerce internationalen_US
dc.typeGoverning body documentsen_US
dc.subject.meshqualifierstandardsen_US


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record